Plerixafor is superior to conventional chemotherapy for first-line stem cell mobilisation, and is effective even in heavily pretreated patients - Top-Institutions - MDSpire

Plerixafor is superior to conventional chemotherapy for first-line stem cell mobilisation, and is effective even in heavily pretreated patients

  • By

  • R E Clark

  • J Bell

  • J O Clark

  • B Braithwaite

  • U Vithanarachchi

  • N McGinnity

  • T Callaghan

  • S Francis

  • R Salim

  • October 31, 2014

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Hematology
    • Oncology
    • Stem Cell Transplantation

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Hematology
    • Oncology
    • Stem Cell Transplantation

  • #3

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Hematology
    • Oncology
    • Stem Cell Transplantation

  • #4

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Hematology
    • Oncology
    • Stem Cell Transplantation

Original Source(s)

Plerixafor is superior to conventional chemotherapy for first-line stem cell mobilisation, and is effective even in heavily pretreated patients

  • by R E Clark, J Bell, J O Clark, B Braithwaite, U Vithanarachchi, N McGinnity, T Callaghan, S Francis, R Salim

  • October 31, 2014

Related Content

CLINICOPATHOLOGICAL FEATURES OF ADULT LYMPHOBLASTIC LYMPHOMA: A RETROSPECTIVE MULTICENTER STUDY FROM TÜRKİYE

Differential expression of immune activation markers in T cells from patients with multiple myeloma

Blocking CD30 on CD19 CAR T cells augments their functional capacities against B-cell leukemia/lymphoma